As per the company’s filing on BSE, the USFDA has informed the company
that it will be lifting the Import alert 66-40 and will be moving to
close out the warning letter issued to the company’s Unit-II at
Vishakhapatnam. The Divi's stock is up 15% or Rs 139 trading at Rs 1062
on NSE at 9.15 am.
The US drug regulator, after its reinspection of the plant during September 11 to 19, 2017, had issued six observations by raising Form-483.
The Company, in its September, 2017 quarter financial results press release, had mentioned that it had filed responses to the USFDA within the given stipulated time.
The US drug regulator, after its reinspection of the plant during September 11 to 19, 2017, had issued six observations by raising Form-483.
The Company, in its September, 2017 quarter financial results press release, had mentioned that it had filed responses to the USFDA within the given stipulated time.
BUY IDEA FUTURE ABOVE 101.50 TG 101.90, 102.50, 103.50 SL 100.90,
BUY AUROPHARMA FUTURE ABOVE 781 TG 784, 788, 793 SL 777,
BUY AUROPHARMA FUTURE ABOVE 781 TG 784, 788, 793 SL 777,
FOR MORE INFORMATION PLEASE VISIT OUR WEBSITE: www.tradenivesh.com
0 Comments